Meta Pixel

News and Announcements

Wych Partners with The Salvation Army to Deliver Fundraising Technology

  • Published June 09, 2022 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Growing Kiwi company, Wych and The Salvation Army team up to improve localised fundraising support.

Wych deliver ingenuous new tech solution for The Salvation Army to keep fundraising local

Auckland, New Zealand, 10/5/2022: Wych Money, an AI-powered financial personal assistant which takes the effort out of managing personal finances, has developed a QR code based option for New Zealanders to donate money safely to The Salvation Army.

Wych have designed a donation model based on QR code technology, which has been around for many years but popularised through the pandemic. With the public already using QR codes, it provided a sensible solution to make it easy for generous kiwis to scan and donate.

Register Interest

The generation of Wych’s localised codes will allow 80 different areas around New Zealand to raise support through card based donations and the money will directly impact the community they are in. 

Wych CEO, Dermot Butterfield, “We have created a product that can adapt to the needs of any fundraisers. We have been in discussions with The Salvation Army for several months. Our team moved with agility from contract signing to delivery in a little under a month. 

Wych have recently completed activation onto the Australian Competition and Consumer Commission register, proving they have the know-how and technology to handle financial data safely. The technology used permits a safe and personal approach to donation where the donator can do everything from the comfort of their own device. 

“We are so pleased to be partnering with The Salvation Army as our first large scale partner.” continued Dermot, “I was able to donate at my local Salvation Army this weekend and found a real sense of pride over our first iteration of Wych Donate”.

Register Interest

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now